TIMP2 and neuroblastoma: On one hand, TIMP2 was found to predict better prognosis in endometrial9 and pancreatic carcinomas10, whereas indicate poorer outcome in neuroblastoma, and head and neck, hepatocellular, Canine mammary, laryngeal, renal, colorectal, oral or tong squamous cell cancers11–18.